What is so bad about reverse epidemiology anyway?

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Metabolic Syndrome Research

Background:

• The concept of "reverse epidemiology" describes the paradoxical association of cardiovascular risk factors (obesity, hypercholesterolemia, hypertension) with improved survival in chronic disease states, notably in dialysis patients.
• This phenomenon contrasts with the general population, where these factors are linked to increased mortality, raising questions about statistical confounding versus biological plausibility.

Purpose of the Study:

• To explore the implications of "reverse epidemiology" in dialysis patients, challenging the prevailing Framingham paradigm.
• To investigate whether the observed survival paradoxes in dialysis patients represent statistical artifacts or possess biological underpinnings.
• To identify potential new targets for improving longevity in patients with chronic diseases.

Main Methods:

• Analysis of the obesity-mortality association curves in dialysis patients compared to the general population.
• Evaluation of the potential for residual confounding versus biological plausibility of the observed survival paradoxes.
• Consideration of Hill's criteria for causation in the context of dialysis patient survival and risk factors.

Main Results:

• The study highlights a debate on whether the "crossing curves" of obesity-mortality in dialysis patients are statistical artifacts or reflect genuine biological phenomena.
• While some aspects align with criteria for causation, definitive pathophysiological pathways and evidence from randomized controlled trials are lacking.
• The potential for a paradigm shift in managing chronic disease states beyond current guidelines is suggested.

Conclusions:

• Dismissing "reverse epidemiology" prematurely may hinder understanding of how to enhance longevity in dialysis patients.
• Further research, including animal models and randomized trials, is crucial to validate pathophysiological links and the efficacy of interventions like nutritional support.
• Studying these survival paradoxes could lead to revised therapeutic targets for chronic disease populations, moving beyond traditional risk factor management.